Parnassus Investments, LLC Moderna, Inc. Transaction History

Parnassus Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$118.38 - $210.04 $6.32 Million - $11.2 Million	-53,393 Reduced 7.65%	644,208 $116 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $11.5 Million - $19 Million	97,761 Added 16.3%	697,601 $82.5 Million
Q1 2022 May 11, 2022	BUY	$126.46 - $235.05 $75.9 Million - $141 Million	599,840 New	599,840 $103 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Parnassus Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Parnassus Investments, LLC with notifications on news.